CRNX Crinetics Pharmaceuticals Inc

USD 59.66 +0.74 ( +1.26)%
Icon

Crinetics Pharmaceuticals Inc (CRNX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 59.66

+0.74 (+1.26)%

USD 5.46B

0.86M

USD 73.13(+22.57%)

USD 15.00 (-74.86%)

Icon

CRNX

Crinetics Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 59.66
+0.74 ( +1.26)%

Crinetics Pharmaceuticals Inc (CRNX) Stock Forecast

Show ratings and price targets of :
USD 73.13
(+22.57%)

Based on the Crinetics Pharmaceuticals Inc stock forecast from 10 analysts, the average analyst target price for Crinetics Pharmaceuticals Inc is USD 73.13 over the next 12 months. Crinetics Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Crinetics Pharmaceuticals Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Crinetics Pharmaceuticals Inc’s stock price was USD 59.66. Crinetics Pharmaceuticals Inc’s stock price has changed by -0.25% over the past week, +12.35% over the past month and +108.24% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...